Bayer exercises option for BiTE antibody

Bayer AG (Xetra:BAY) exercised its option to license exclusive, worldwide rights to a Bispecific T cell engager (BiTE) antibody from Micromet Inc. (NASDAQ:MITI) against an undisclosed solid tumor targ...